The activin receptor-like kinase 7 (ALK7) pathway got another vote of confidence as Rona Therapeutics Inc. came to terms with ...
Two phase III successes have delivered validation for Bristol Myers Squibb Co. across two strategically important programs, ...
Sitryx Therapeutics Ltd. has delivered the first clinical data for a new mechanism of action (MOA) in atopic dermatitis and ...
Psychiatric drug discovery is “ready for transformation 2.0,” Roger McIntyre told his audience at the annual congress of the ...
Diosynvax Ltd., a spinout of the University of Cambridge, together with partners at the University of Cambridge, University ...
Saniona AB has shown that SAN-2465, its GABA-A α5 negative allosteric modulator, significantly enhanced hippocampal synaptic ...
Rona Therapeutics Co. Ltd. has granted F. Hoffmann-La Roche Ltd. an exclusive worldwide license for Rona’s investigational ...
Gan & Lee Pharmaceuticals Co. Ltd. recently presented preclinical data regarding GZR-102, a novel once-weekly fixed-ratio ...
U.S. President Donald Trump signed in the third quarter directly impact the biopharma and med-tech space, one of them has continued to court controversy as the Senate considers the nomination of Heidi ...
Pacific, including global submissions and approvals, and other regulatory decisions and designations: Everest Medicines, Nanoscope, Novocure.
Shenzhen Chipscreen Biosciences Co. Ltd. has obtained IND approval from China’s National Medical Products Administration (NMPA) for CS-43158 tablets, a new molecular entity for the treatment of acute ...
Targeting fibroblast activation protein (FAP) is a promising immunotherapeutic approach to remodel the tumor microenvironment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results